Fresenius Kabi AG

Fresenius Kabi AG is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Established with a commitment to improving patient outcomes, the company operates in over 100 countries worldwide.

With a strong focus on innovation, Fresenius Kabi develops products that cater to the needs of critically ill patients. The company’s extensive portfolio includes intravenous (IV) drugs, infusion therapies, and medical devices.

Fresenius Kabi is dedicated to quality and safety, ensuring that all products meet stringent regulatory standards. The company invests significantly in research and development to advance its offerings and address emerging healthcare challenges.

Core Activities:

• Infusion Therapy: Providing essential IV medications and solutions.
• Clinical Nutrition: Offering nutritional products for patients who require specialized dietary support.
• Transfusion Technology: Developing systems and products for safe blood transfusions.

The vision of Fresenius Kabi is to be a trusted partner in healthcare, enhancing the quality of life for patients around the globe. The company emphasizes sustainability and corporate responsibility, striving to minimize its environmental impact while delivering high-quality healthcare solutions.

Fresenius Kabi’s commitment to excellence is reflected in its highly skilled workforce, which is dedicated to advancing medical care and improving patient outcomes. Through collaboration with healthcare professionals, the company aims to provide innovative solutions that meet the evolving needs of the healthcare industry.